CN Stock MarketDetailed Quotes

Xiamen Amoytop Biotech (688278)

Watchlist
  • 75.90
  • -0.28-0.37%
Market Closed Jan 16 15:00 CST
30.98BMarket Cap32.97P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xiamen Amoytop Biotech (688278) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
26.85%2.48B
26.96%1.51B
23.48%673.35M
34.13%2.82B
33.90%1.95B
31.68%1.19B
30.05%545.3M
37.55%2.1B
27.69%1.46B
26.40%903.58M
Operating revenue
26.85%2.48B
26.96%1.51B
23.48%673.35M
34.13%2.82B
33.90%1.95B
31.68%1.19B
30.05%545.3M
37.55%2.1B
27.69%1.46B
26.40%903.58M
Total operating cost
32.49%1.72B
25.51%1.03B
21.34%460.73M
31.05%1.88B
30.42%1.3B
27.57%816.75M
24.66%379.69M
23.30%1.44B
14.73%996.11M
17.68%640.25M
Operating cost
42.02%184.53M
34.27%106.03M
21.71%45.96M
31.03%183.51M
38.79%129.93M
23.73%78.97M
0.09%37.77M
-17.24%140.05M
-23.25%93.62M
-14.77%63.82M
Operating tax surcharges
32.33%12.71M
24.80%7.64M
23.38%3.45M
22.23%13.73M
21.45%9.61M
26.78%6.12M
31.27%2.79M
43.30%11.24M
40.40%7.91M
37.43%4.83M
Operating expense
29.72%1.01B
19.85%598.91M
15.36%279.06M
31.16%1.11B
29.13%777.95M
20.99%499.73M
29.96%241.91M
20.71%848.8M
10.21%602.43M
15.81%413.04M
Administration expense
25.08%237.84M
17.48%140.33M
23.86%67.37M
32.35%278.34M
24.79%190.15M
43.78%119.45M
29.70%54.39M
51.98%210.31M
58.10%152.37M
40.23%83.08M
Financial expense
-27.99%-2.38M
-84.14%-2.62M
-147.29%-1.86M
54.78%-2.18M
39.54%-1.86M
17.61%-1.42M
30.08%-750.94K
-15.10%-4.81M
8.94%-3.08M
20.35%-1.73M
-Interest expense (Financial expense)
113.90%764.38K
65.61%379.94K
3.12%117.67K
-10.57%452.68K
-3.77%357.36K
-8.10%229.42K
-2.77%114.11K
-18.46%506.17K
-25.11%371.36K
-28.61%249.63K
-Interest Income (Financial expense)
-45.44%-3.39M
-61.84%-2.9M
-100.95%-1.96M
55.62%-2.94M
51.36%-2.33M
42.52%-1.79M
25.64%-975.13K
-45.04%-6.63M
-34.96%-4.79M
-24.37%-3.11M
Research and development
44.48%279.34M
53.46%174.8M
53.18%66.75M
28.15%294.71M
35.34%193.34M
47.53%113.91M
15.55%43.58M
53.48%229.98M
41.44%142.86M
48.74%77.21M
Credit Impairment Loss
117.53%95.99K
966.46%986.04K
512.20%779.81K
-678.02%-3.61M
11.81%-547.47K
88.74%-113.8K
135.01%127.38K
-132.95%-463.8K
13.87%-620.78K
-518.11%-1.01M
Asset Impairment Loss
----
----
----
----
----
----
----
---12.76M
----
----
Other net revenue
Fair value change income
-17.31%1.07M
-31.78%590.54K
--40.46K
-66.69%882.87K
689.64%1.29M
708.65%865.58K
----
566.55%2.65M
-86.27%163.84K
-76.82%107.04K
Invest income
14.70%2.62M
12.18%1.87M
-2.99%1.35M
14.27%4.05M
1.13%2.28M
-11.91%1.67M
-26.34%1.4M
0.74%3.55M
5.72%2.26M
5.52%1.9M
Asset deal income
-68.19%14.47K
-68.65%14.09K
-77.69%10.03K
639.43%65.37K
456.60%45.5K
941.82%44.95K
--44.95K
-90.80%8.84K
-91.49%8.17K
-94.34%4.31K
Other revenue
34.79%19.26M
-16.12%8.15M
55.04%5.17M
46.04%33.56M
-6.00%14.29M
125.39%9.72M
21.96%3.33M
-40.87%22.98M
-55.84%15.2M
-85.99%4.31M
Operating profit
16.11%781.39M
29.05%497.15M
29.00%219.96M
42.60%970.74M
40.00%672.95M
43.41%385.24M
43.30%170.52M
67.28%680.72M
54.03%480.68M
31.82%268.64M
Add:Non operating Income
16.13%744.46K
12.26%598.96K
-54.32%229.2K
50.59%682.28K
129.28%641.07K
119.43%533.53K
188.13%501.72K
47.52%453.06K
182.29%279.61K
241.61%243.14K
Less:Non operating expense
83.70%51.13M
6.43%21.48M
-19.57%10.98M
-0.31%40.39M
-16.39%27.84M
-9.20%20.18M
-10.58%13.65M
-21.02%40.52M
-26.15%33.29M
-22.88%22.22M
Total profit
13.20%731M
30.27%476.27M
32.95%209.22M
45.32%931.03M
44.25%645.75M
48.22%365.6M
51.46%157.37M
80.00%640.65M
67.61%447.67M
40.91%246.66M
Less:Income tax cost
-29.18%64.87M
-21.02%48.38M
-5.16%27.09M
21.38%103.42M
16.30%91.6M
37.72%61.26M
44.77%28.56M
23.65%85.21M
18.11%78.77M
7.45%44.48M
Net profit
20.21%666.12M
40.60%427.89M
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
Net profit from continuing operation
20.21%666.12M
40.60%427.89M
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
Net profit of parent company owners
20.21%666.12M
40.60%427.89M
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
Earning per share
Basic earning per share
20.59%1.64
40.00%1.05
40.63%0.45
48.18%2.03
49.45%1.36
50.00%0.75
52.38%0.32
92.96%1.37
85.71%0.91
51.52%0.5
Diluted earning per share
20.59%1.64
40.00%1.05
40.63%0.45
48.18%2.03
49.45%1.36
50.00%0.75
52.38%0.32
92.96%1.37
85.71%0.91
51.52%0.5
Other composite income
-81.74K
Other composite income of parent company owners
---81.74K
----
----
----
----
----
----
----
----
----
Total composite income
20.19%666.04M
40.60%427.89M
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
Total composite income of parent company owners
20.19%666.04M
40.60%427.89M
41.40%182.13M
49.00%827.6M
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
--
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue 26.85%2.48B26.96%1.51B23.48%673.35M34.13%2.82B33.90%1.95B31.68%1.19B30.05%545.3M37.55%2.1B27.69%1.46B26.40%903.58M
Operating revenue 26.85%2.48B26.96%1.51B23.48%673.35M34.13%2.82B33.90%1.95B31.68%1.19B30.05%545.3M37.55%2.1B27.69%1.46B26.40%903.58M
Total operating cost 32.49%1.72B25.51%1.03B21.34%460.73M31.05%1.88B30.42%1.3B27.57%816.75M24.66%379.69M23.30%1.44B14.73%996.11M17.68%640.25M
Operating cost 42.02%184.53M34.27%106.03M21.71%45.96M31.03%183.51M38.79%129.93M23.73%78.97M0.09%37.77M-17.24%140.05M-23.25%93.62M-14.77%63.82M
Operating tax surcharges 32.33%12.71M24.80%7.64M23.38%3.45M22.23%13.73M21.45%9.61M26.78%6.12M31.27%2.79M43.30%11.24M40.40%7.91M37.43%4.83M
Operating expense 29.72%1.01B19.85%598.91M15.36%279.06M31.16%1.11B29.13%777.95M20.99%499.73M29.96%241.91M20.71%848.8M10.21%602.43M15.81%413.04M
Administration expense 25.08%237.84M17.48%140.33M23.86%67.37M32.35%278.34M24.79%190.15M43.78%119.45M29.70%54.39M51.98%210.31M58.10%152.37M40.23%83.08M
Financial expense -27.99%-2.38M-84.14%-2.62M-147.29%-1.86M54.78%-2.18M39.54%-1.86M17.61%-1.42M30.08%-750.94K-15.10%-4.81M8.94%-3.08M20.35%-1.73M
-Interest expense (Financial expense) 113.90%764.38K65.61%379.94K3.12%117.67K-10.57%452.68K-3.77%357.36K-8.10%229.42K-2.77%114.11K-18.46%506.17K-25.11%371.36K-28.61%249.63K
-Interest Income (Financial expense) -45.44%-3.39M-61.84%-2.9M-100.95%-1.96M55.62%-2.94M51.36%-2.33M42.52%-1.79M25.64%-975.13K-45.04%-6.63M-34.96%-4.79M-24.37%-3.11M
Research and development 44.48%279.34M53.46%174.8M53.18%66.75M28.15%294.71M35.34%193.34M47.53%113.91M15.55%43.58M53.48%229.98M41.44%142.86M48.74%77.21M
Credit Impairment Loss 117.53%95.99K966.46%986.04K512.20%779.81K-678.02%-3.61M11.81%-547.47K88.74%-113.8K135.01%127.38K-132.95%-463.8K13.87%-620.78K-518.11%-1.01M
Asset Impairment Loss -------------------------------12.76M--------
Other net revenue
Fair value change income -17.31%1.07M-31.78%590.54K--40.46K-66.69%882.87K689.64%1.29M708.65%865.58K----566.55%2.65M-86.27%163.84K-76.82%107.04K
Invest income 14.70%2.62M12.18%1.87M-2.99%1.35M14.27%4.05M1.13%2.28M-11.91%1.67M-26.34%1.4M0.74%3.55M5.72%2.26M5.52%1.9M
Asset deal income -68.19%14.47K-68.65%14.09K-77.69%10.03K639.43%65.37K456.60%45.5K941.82%44.95K--44.95K-90.80%8.84K-91.49%8.17K-94.34%4.31K
Other revenue 34.79%19.26M-16.12%8.15M55.04%5.17M46.04%33.56M-6.00%14.29M125.39%9.72M21.96%3.33M-40.87%22.98M-55.84%15.2M-85.99%4.31M
Operating profit 16.11%781.39M29.05%497.15M29.00%219.96M42.60%970.74M40.00%672.95M43.41%385.24M43.30%170.52M67.28%680.72M54.03%480.68M31.82%268.64M
Add:Non operating Income 16.13%744.46K12.26%598.96K-54.32%229.2K50.59%682.28K129.28%641.07K119.43%533.53K188.13%501.72K47.52%453.06K182.29%279.61K241.61%243.14K
Less:Non operating expense 83.70%51.13M6.43%21.48M-19.57%10.98M-0.31%40.39M-16.39%27.84M-9.20%20.18M-10.58%13.65M-21.02%40.52M-26.15%33.29M-22.88%22.22M
Total profit 13.20%731M30.27%476.27M32.95%209.22M45.32%931.03M44.25%645.75M48.22%365.6M51.46%157.37M80.00%640.65M67.61%447.67M40.91%246.66M
Less:Income tax cost -29.18%64.87M-21.02%48.38M-5.16%27.09M21.38%103.42M16.30%91.6M37.72%61.26M44.77%28.56M23.65%85.21M18.11%78.77M7.45%44.48M
Net profit 20.21%666.12M40.60%427.89M41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M
Net profit from continuing operation 20.21%666.12M40.60%427.89M41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M
Net profit of parent company owners 20.21%666.12M40.60%427.89M41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M
Earning per share
Basic earning per share 20.59%1.6440.00%1.0540.63%0.4548.18%2.0349.45%1.3650.00%0.7552.38%0.3292.96%1.3785.71%0.9151.52%0.5
Diluted earning per share 20.59%1.6440.00%1.0540.63%0.4548.18%2.0349.45%1.3650.00%0.7552.38%0.3292.96%1.3785.71%0.9151.52%0.5
Other composite income -81.74K
Other composite income of parent company owners ---81.74K------------------------------------
Total composite income 20.19%666.04M40.60%427.89M41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M
Total composite income of parent company owners 20.19%666.04M40.60%427.89M41.40%182.13M49.00%827.6M50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --------------Unqualified opinion----
Auditor --------------Rong Cheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -